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Expansion of polyglutamine stretches leads to the forma-
tion of polyglutamine-containing neuronal aggregates
and neuronal death in nine diseases for which there cur-
rently are no treatments or cures. This is largely due to a
lack in understanding of the mechanisms by which ex-
panded polyglutamine regions contribute to aggregation
and disease. To complicate matters further, several of
the polyglutamine-disease related proteins, including
ataxin-3, have a multistage aggregation mechanism in
which flanking domain self-assembly precedes polyglu-
tamine aggregation yet is influenced by polyglutamine
expansion. How polyglutamine expansion influences
flanking domain aggregation is poorly understood. Here,
we use a combination of mass spectrometry and biophys-
ical approaches to investigate this issue for ataxin-3. We
show that the conformational dynamics of the flanking
Josephin domain in ataxin-3 with an expanded polyglu-
tamine tract are altered in comparison to those exhibited
by its nonexpanded counterpart, specifically within the
aggregation-prone region of the Josephin domain (amino
acid residues 73–96). Expansion thus exposes this region
more frequently in ataxin-3 containing an expanded poly-
glutamine tract, providing a molecular explanation of why
aggregation is accelerated upon polyglutamine expan-
sion. Here, harnessing the power of ion mobility spec-
trometry-mass spectrometry, oligomeric species formed
during aggregation are characterized and a model for
oligomer growth proposed. The results suggest that a
conformational change occurs at the dimer level that ini-
tiates self-assembly. New insights into ataxin-3 fibril ar-
chitecture are also described, revealing the region of the
Josephin domain involved in protofibril formation and
demonstrating that polyglutamine aggregation proceeds
as a distinct second step after protofibril formation with-
out requiring structural rearrangement of the protofibril
core. Overall, the results enable the effect of polyglu-
tamine expansion on every stage of ataxin-3 self-assem-
bly, from monomer through to fibril, to be described and a
rationale for expedited aggregation upon polyglutamine
expansion to be provided. Molecular & Cellular Pro-
teomics 14: 10.1074/mcp.M114.044610, 1241–1253, 2015.
Polyglutamine (polyQ)1 diseases comprise a group of he-
reditary neurodegenerative disorders in which expansion of
polyQ stretches within their causative proteins induces pro-
tein aggregation and the formation of polyQ-containing neu-
ronal aggregates (1). The mechanisms by which expanded
polyQ regions contribute to aggregation and disease are not
well understood. In all cases, polyQ length is negatively cor-
related with the age of onset of the disease (2), but the various
polyQ disorders are associated with different neurodegenera-
tive symptoms and affect different regions of the brain (3).
Several of the polyQ proteins, including ataxin-3 (atx-3) (4)
and huntingtin (5), have been shown to aggregate in vitro
through a complex multidomain misfolding pathway (6) in
which flanking domain aggregation precedes polyQ aggrega-
tion. Increasing evidence also suggests a key role for misfold-
ing of flanking regions in the process of polyQ aggregation in
vivo (7–10). Thus, as the proteins have no sequence similarity
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other than in their polyQ regions, flanking domain content may
be significant in determining the disease state and neuronal-
specific selectivity. Given that there is growing support to
suggest that the toxic entities in polyQ diseases are the sol-
uble oligomers and assembly intermediates, rather than the
fibrillar aggregates (11), effective therapeutics may be gener-
ated by targeting flanking domain interactions (12) rather than
targeting the polyQ region itself. An enhanced understanding
of the molecular mechanisms of assembly of polyQ proteins is
required, as is a greater comprehension of the effects of
polyQ length on the structure, dynamics, aggregation propen-
sity, and oligomerisation pathway of the flanking domains.
Here, we set out to determine the influence of an expanded
polyQ tract on each stage of atx-3 aggregation by harnessing
the power of mass-spectrometry-based approaches to iden-
tify and characterize assembly mechanisms (13, 14).
Atx-3 consists of a structured N-terminal Josephin domain
(JD), which has ubiquitin protease activity (15) and an intrin-
sically disordered C-terminal region, the latter containing sev-
eral ubiquitin-interacting motifs (UIMs) followed by the polyQ
tract and a variable region (16) (Fig. 2A). In vivo, expansion of
the polyQ stretch beyond ca. 55 glutamine residues results in
Machado–Joseph disease (17). Consistent with this, atx-3
with a polyQ tract beyond ca. 55 glutamine residues aggre-
gates into amyloid-like fibrils rapidly in vitro (18). Aggregation
proceeds by means of a two-stage pathway (4): the first stage
resulting in the production of SDS-sensitive, short, curvilinear,
protofibrils, and the second producing long-straight and SDS-
resistant mature fibrils. The first stage involves self-associa-
tion of the JD (19) and occurs in all atx-3 variants whether or
not they contain a polyQ region of nonpathological length
(nonexpanded, 12–40 glutamine residues (17)), an expanded
polyQ region of disease length (polyQ-expanded, 55–84 glu-
tamine residues (17)), or are devoid of a polyQ region (20). The
second stage occurs only in polyQ-expanded atx-3 and in-
volves hydrogen bonding between side-chains in the polyQ
region (21), which renders aggregation irreversible.
Despite the fact that the first stage of atx-3 aggregation
does not require the polyQ tract, aggregation of polyQ-ex-
panded atx-3 occurs more rapidly (with a shorter lag time)
than aggregation of nonexpanded atx-3 (4, 20). The precise
molecular mechanism for this observation has yet to be elu-
cidated. An initial hypothesis was that polyQ expansion de-
stabilizes atx-3, allowing the JD to adopt misfolded, aggre-
gation-prone conformations more readily (15, 18). However, a
study comparing atx-3 constructs with polyQ regions of dif-
ferent lengths showed that polyQ expansion does not affect
the folding/unfolding kinetics or thermodynamic stability of
the JD (22). Consequently, it has been postulated that the
expanded polyQ tract may perturb the structure of the JD
without affecting its stability (20).
We set out to address why aggregation occurs more rapidly
in atx-3 with an expanded polyQ tract by studying mono-
meric, oligomeric, and fibril structures for atx-3 with a patho-
logical length polyQ tract of 77 glutamines with a single,
naturally occurring, lysine residue in the fourth position
(named atx-3(78Q)); atx-3 with a nonpathological length
polyQ tract of 13 glutamines (also with a single lysine residue
in the fourth position) (atx-3(14Q)); and the isolated JD. Re-
sults from a combination of electrospray ionization-ion mobil-
ity spectrometry-mass spectrometry (ESI-IMS-MS), limited
proteolysis, fluorescence spectroscopy, and transmission
electron microscopy (TEM) analyses confirm that protofibrils
of these three atx-3 constructs are formed through equivalent
processes and reveal that the resulting protofibril cores are
similar, if not identical. Limited proteolysis experiments com-
bined with MS analyses provide evidence that an expanded
polyQ tract alters the conformational dynamics of the JD,
exposing its aggregation-prone region more frequently than in
its nonexpanded counterparts, rationalizing the enhanced ag-
gregation potential of the polyQ-expanded protein. Finally,
oligomers populated en route to fibrils are examined by ESI-
IMS-MS and a model for oligomer growth is provided. To-
gether these results reveal how polyQ length affects each
stage of atx-3 aggregation and demonstrate how different
MS-based techniques can provide information about each
stage of the aggregation mechanism.
EXPERIMENTAL PROCEDURES
Protein Preparation—cDNAs encoding human ataxin-3 (14Q) (iso-
form 2 ((16) (P54252–2)), the JD (atx-3 residues 1–182), and polyQ-
expanded atx-3 (78Q) (isoform 2, G3R directly following polyQ tract
(VAR 013689) (23)) were subcloned into pDEST17 plasmid vectors
(19). Upstream of the coding site, a sequence coding for an N-termi-
nal hexa-histidine tag and a linker region containing a cleavage site
for the recombinant tobacco etch virus protease were incorporated.
The proteins were expressed in Escherichia coli strains BL21(DE3)-
pLysS or BL21-SI and soluble protein purified by nickel-affinity chro-
matography followed by gel-filtration chromatography. Purified pro-
tein samples were snap-frozen and stored at 80 °C. Each
recombinant protein construct retains the hexa-histidine tag and
linker region (SYYHHHHHHLENLYFQG) as removal of this from the
atx-3(78Q) construct led to insolubility. The presence of the hexa-
histidine tag and linker region did not significantly affect the CCSs
measured for the JD or atx-3(14Q) by IMS-MS nor the observed
products of limited proteolysis. Protofibril structures formed were also
not effected (data not shown). Protein samples were buffer ex-
changed into 250 mM ammonium bicarbonate, 1 mM DTT, pH 8.1, for
all aggregation studies by use of ZEBATM desalting columns (Thermo
Fisher Scientific, Waltham, MA, USA), prepared at a concentration of
20–40 M and used immediately. A slightly basic pH was used to
ensure that the pH remained constant during the time-course of
aggregation using the volatile buffers required for ESI-MS. Under
these conditions, atx-3 aggregates by the same two-step mechanism
observed in nonvolatile buffers at pH 7.4 (20).
ESI-(IMS)-MS Analysis—A Synapt High Definition Mass Spectrom-
eter (HDMS) quadrupole time-of-flight mass spectrometer (Waters
Corporation, Manchester, UK) was used to analyze all samples. Sam-
ples were introduced into the instrument by direct infusion nanoESI
with in-house prepared gold-coated borosilicate glass capillaries. MS
and IMS-MS spectra were recorded in nanoESI positive mode using
the following instrument parameters: cone voltage 30–60 V; source
temperature 60 °C; backing pressure 3.5–4.5 mBar; traveling wave
height 8 V; traveling wave speed 300 m/s; IMS gas flow 20 ml/min.
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Data were processed by use of MassLynx v4.1 and Driftscope soft-
ware supplied with the mass spectrometer. Driftscope plots show
drift time on the x axis, m/z on the y axis, and relative ion intensity on
the z axis (square-root scale). Estimated CCSs for different species
were calculated by use of a calibration curve using beta-lactoglobulin,
avidin, alcohol dehydrogenase, and concanavalin A, following the
protocol previously described (24).
Fibril Growth Experiments—Thioflavin T (ThT) fluorescence was
recorded on a FLUOstar Omega reader (BMG, Labtech Gmbh, Or-
tenberg, Germany) from a 96-well black-wall plate (CostarTM,
Tewkesbury, MA, USA) sealed with clear sealing film. Samples of 100
l volume contained 40 M protein in 250 mM ammonium bicarbon-
ate, 1 mM DTT, 20 M ThT, pH 8.1, and were incubated at 37 °C
without shaking. Fluorescence measurements were acquired for three
or more replicates of each sample over 48 h. Samples were incubated
for a further 48 h at 37 °C. Samples from the growth assays were
examined on freshly ionized carbon- and formvar-coated TEM grids
negatively stained with 2% (w/v) uranyl acetate by use of a JEM-1400
microscope (JEOL, Tokyo, Japan). Aliquots of samples were removed
at various time points through aggregation for analysis by ESI-
IMS-MS in real time.
Analysis of JD Peptides and Cross-Seeding Experiments—Pep-
tides composed of JD residues 48–59, 73–96, 144–154, and 159–
167 (with N-terminal acetylation and C-terminal amidation) were pur-
chased from Biosynthesis Inc. (Lewisville, TX) Peptides were
incubated at 20 M concentration in 250 mM ammonium bicarbonate,
1 mM DTT, 20 M ThT, pH 8.1, for 24 h at 37 °C without shaking after
which time ThT fluorescence was measured on a plate reader and
TEM performed as above. The ThT fluorescence of the peptides was
also monitored, immediately after their dilution into buffer, over 24 h
under the conditions stated above. For cross-seeding experiments,
assays were performed as described above but using 20 M protein
in the presence of a 1:1 molar ratio of JD peptide. Boxplots were
created by use of the web tool BoxPlotR (25).
Limited Proteolysis-Fibrils—For limited proteolysis experiments on
fibrils, fibrillar material formed was collected by centrifugation (16,000
g, 30 min) and resuspended in fresh buffer as described above.
Proteinases, bovine trypsin, or proteinase K (Sigma Aldrich), were
added at 1:100 or 1:50 proteinase to protein molar ratios, respec-
tively, and proteolysis was allowed to proceed for 30 min at 37 °C
before reactions were quenched by the addition of 10% (v/v) formic
acid. Fibrillar material remaining after digestion was separated from
soluble material, again by centrifugation (16,000 g, 30 min). The
insoluble fraction was depolymerized in 100% (v/v) hexafluoroisopro-
panol (for 3 days at 300 rpm, 37 °C). Fibrillar samples were air dried
and redissolved in 50:48.8:0.2 acetonitrile/water/formic acid (v/v/v)
prior to ESI-MS analysis. Supernatant samples were analyzed directly
by ESI-MS.
Limited Proteolysis-Monomers—For limited proteolysis experi-
ments on monomeric samples (20 M concentration), bovine trypsin
was added at 1:100 proteinase:protein molar ratio and samples incu-
bated for 15 min at 37 °C prior to ESI-MS analysis. To monitor limited
proteolysis over time for the JD, atx-3(14Q), and atx-3(78Q), bovine
trypsin was added at 1:10 (w/w) proteinase to protein ratio and
samples incubated for 1 min, 4 min, and 8 min at 37 °C prior to
ESI-MS analysis in real time. A peptide standard (MAEGGVTSEDYR,
N-terminally acetylated and C-terminally amidated) was added to
each protein construct prior to the addition of trypsin in a 5:1 protein:
peptide molar ratio. The relative intensities of tryptic peptide ions
were normalized to the intensity of the peptide standard in each case
to allow for relative quantification of the rates of tryptic peptide
production. Tryptic peptides resulting from limited proteolysis of the
JD and atx-3 were separated by IMS and further characterized by
collision-induced dissociation (CID) MS/MS sequencing when re-
quired. Experiments were conducted in triplicate and representative
spectra are shown.
Modeling—Isotropic assembly (cross-section  is related to the
oligomeric state n by monomer  n
2/3) and linear assembly models of
oligomers (  an  k, where a  area added per monomer subunit
and k is related to the fibril cap) were produced as described previ-
ously (14). The ring structures were calculated following the method
used by Bernstein et al. (26). The MOBCAL algorithm was modified to
allow for coarse-grain modeling of a complex as described previously
(27). The CCS measurements obtained for the most compact JD
oligomers observed were used in the modeling calculations (lowest
charge state observed for each oligomer). Alternatively, the values for
the most highly populated oligomer charge states did not affect the
model to which the data best fitted.
RESULTS
An Expanded PolyQ Tract Does Not Alter Protofibril Struc-
ture—Although the second stage of aggregation has been
attributed to intermolecular hydrogen bonding in the ex-
panded polyQ tract (21), the molecular architectures of fibrils
formed from atx-3 have not been reported in any detail to
date. To improve our understanding, we used limited prote-
olysis combined with ESI-MS to elucidate the regions of atx-3
involved in the protected core of JD, atx-3(14Q), and atx-
3(78Q) protofibrils, as well as atx-3(78Q) mature fibrils.
The aggregation reactions of the JD, atx-3(14Q), and atx-
3(78Q) were monitored by ThT fluorescence and TEM over
time. ThT fluorescence increases upon binding to beta-rich
structures and reports on the first stage of atx-3 aggregation.
The second polyQ-dependent step of aggregation does not
affect ThT fluorescence and proceeds after the initial ThT
increase is observed (4). Consistent with previous observa-
tions (4, 20), ThT fluorescence kinetics indicated that protofi-
bril formation occurs more rapidly for atx-3(78Q) than for
atx-3(14Q) or the JD (Fig. 1A). The appearance of short,
curvilinear protofibrils, with similar morphologies was ob-
served for all three constructs by TEM after 48 h incubation
(Figs. 1B-1G). A small proportion of long-straight fibrils was
observed in the atx-3(78Q) sample at this time point (Fig. 1G).
Full maturation of atx-3(78Q) protofibrils into SDS-resistant
fibrils was observed after 96 h incubation (Figs. 1H and 1I).
Mature fibrils were SDS-insoluble (measured by SDS-PAGE
(not shown)) and TEM analysis showed no evidence for the
presence of protofibrils in this fibril sample. Glutamine Binding
Protein (QBP-1) (28), an 11-residue peptide that inhibits the
second stage of aggregation of polyQ-expanded atx-3 while
not affecting protofibril formation (4), was used to stall the
aggregation of atx-3(78Q) at the protofibril stage. Atx-3(78Q)
incubated in a 1:1 molar ratio with QBP-1 was observed to
undergo very similar aggregation kinetics to those of atx-
3(78Q) alone (Fig. 1A) and formed protofibrils that did not
mature into SDS-insoluble fibrils after 96 h incubation (Figs.
1J and 1K).
To determine the regions of atx-3 involved in the protofibril
and mature fibril cores, limited proteolysis with trypsin was
performed on the fibrillar material obtained from each con-
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struct. Proteolysed fibrillar material was separated from the
soluble products of proteolysis by centrifugation, and the
pellet and supernatant fractions were analyzed by ESI-MS.
The pelleted fraction was depolymerized in 100% hexafluo-
roisopropanol prior to MS analysis (see Methods). Mass spec-
tra obtained from analysis of the depolymerized fibrillar ma-
terial for atx-3(14Q) and atx-3(78Q) protofibrils trapped by the
addition of QBP-1 were indistinguishable, indicating that the
regions of atx-3 involved in protofibril formation are the same,
irrespective of the length of the polyQ tract (Figs. 2A-2C). The
peptide species identified consisted of residues 48–101, 60–
101, 60–103, 102–190, and 60–190 (the JD consists of resi-
dues 1–182). Peptides spanning residues 60–190 were iden-
tified in the mass spectra of the depolymerized fibrillar
material but were not found in the spectra of the soluble
products of proteolysis. This suggests that the protected core
of the protofibrils lies between residues 60 and 190. The
polyQ regions of atx-3(14Q) and atx-3(78Q) were cleaved
from the protofibril core upon limited proteolysis of their re-
spective protofibrils and were observed in mass spectra of the
soluble supernatant fraction, illustrating, as elucidated previ-
ously (4), that the polyQ stretch is not structurally involved in
the protofibril core (Figs. 2B and 2C). Interestingly, the mass
spectrum obtained of the atx-3(78Q) mature fibril pellet frac-
tion (Fig. 2D) was similar to that obtained for the atx-3(78Q)
protofibril core (Fig. 2C). SDS-PAGE analysis revealed that a
significant amount of SDS-insoluble material remained after
hexafluoroisopropanol treatment of the mature atx-3(78Q) fi-
brils, presumably consisting of SDS-resistant polyQ peptide
sequences (data not shown) that were not depolymerized by
hexafluoroisopropanol. Mass spectra obtained of the soluble
products of proteolysis from atx-3(78Q) protofibrils and ma-
ture fibrils were also remarkably similar (Figs. 2C and 2D), but
fragments containing residues 286–370 were not observed in
mass spectra obtained following limited proteolysis of the
mature fibrils. This suggests that this region, which consists of
six residues N-terminal of the polyQ tract, the expanded
polyQ tract, and a C-terminal arginine residue, forms SDS-
insoluble aggregates. Together, these data indicate that the
mature fibrils consist of two distinct structured regions, the
protofibril core and a polyQ-containing core, that can be
separated by proteolysis. Moreover, the results imply that
involvement of the polyQ stretch in formation of SDS-resist-
ant, mature fibrils occurs as a distinct second step in which
structural rearrangement of the protofibril core is not required.
Limited proteolysis of the protofibrils was performed addi-
tionally with proteinase K, a nonspecific protease, and depo-
lymerized protofibrillar material was analyzed by MS. Again,
the major peptides identified within the depolymerized proto-
fibrillar fractions consisted of residues between 60 and 190
(more specifically, between residues 62 and 183) (supplemen-
tal Fig. 1). This supports the conclusion that the cores of the
JD, atx-3(14Q), and atx-3(78Q) protofibrils are similar, if not
identical.
Global Monomeric Conformation Is Not Significantly Af-
fected by an Expanded PolyQ Tract—In previous work, using
ESI-IMS-MS and limited proteolysis (29), we showed that
atx-3(14Q) is globally more dynamic than the JD, exhibiting a
broader array of conformers, attributable to dynamic move-
ment and flexibility within the C-terminal polyQ-containing
region of atx-3 (29). Here, we compared the conformational
properties of atx-3(14Q) and atx-3(78Q) using ESI-IMS-MS
(Fig. 3).
Under carefully controlled solvent and instrumental condi-
tions, gas-phase measurements of protein conformations can
be reflective of solution-phase structures (30, 31) and the
extent of ionization during the ESI process is reflective of
surface-exposed area and mass (32). ESI mass spectra of
atx-3(14Q) (Fig. 3A) and atx-3(78Q) (Fig. 3B) contain multiple
charge state distributions (CSDs), one representing more
compact ion species (charge states 11 to 19 and 12 to
20, respectively) and several representing more extended
ion conformations (charge states 20 to 42 and 21 to
51, respectively). These spectra are typical for proteins that
contain intrinsically disordered regions and that adopt a wide
range of conformational states with different surface-exposed
areas (33).
FIG. 1. Fibril formation of atx-3. (A) Fibril growth of atx-3 constructs, the JD, atx-3(14Q) and atx-3(78Q), monitored by ThT fluorescence (40
M protein, pH 8.1, 37 °C, three representative traces of each sample are shown). TEM images of (B, C) the JD, (D, E) atx-3(14Q), and (F, G)
atx-3(78Q) samples shown in a recorded after 48 h incubation and TEM images of (H, I) atx-3(78Q) and (J, K) atx-3(78Q)  QBP-1 1:1 molar
ratio recorded after 96 h incubation. Images are shown at two different magnifications (black scale bars 100 nm, white scale bars 500 nm).
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IMS can be used in conjunction with MS to study the
relative size (rotationally averaged CCS) and distribution of
conformations adopted by a protein species. Representative
three-dimensional ESI-IMS-MS datasets of atx-3(14Q) and
atx-3(78Q) indicate that these atx-3 constructs adopt a range
of conformations of similar size, despite differing by 8 kDa in
molecular mass (Figs. 3C and 3D, respectively). Ion mobility
arrival time distributions (ATDs) for individual charge states of
each protein species were extracted from the three-dimen-
sional ESI-IMS-MS datasets, and modal drift times were used
to estimate a CCS for each ion species (Fig. 3E). At the lowest
charge states observed (11 to 15), atx-3(14Q) conformers
had shorter drift times and smaller CCSs than the equivalent
atx-3(78Q) conformers. These conformers are each 20%
larger in size than expected if atx-3(14Q) and atx-3(78Q) ex-
hibited compact globular structures (based on their mass and
an average density of 0.44 Da/Å3) (34). The difference in CCS
measurement for these two species is consistent with that
expected for a species with an increase in mass of 8 kDa (i.e.
an extra 64Q residues) exhibiting a globular/compact confor-
mation. The wide spread of charge state ions with their asso-
ciated CCS measurements exhibited by both atx-3 species,
and the presence of multiple CSDs within their MS spectra
with higher intensity at lower charge states supports the no-
tion that the proteins have both structured and disordered
regions (35). (For charge states 16  to 20 , the global
conformations populated by atx-3(78Q) are as compact as
those populated by atx-3(14Q). This indicates that there is
FIG. 2. Limited proteolysis of protofibrils and mature fibrils. (A) Schematic illustrations of atx-3(14Q) (left) and atx-3(78Q) (right) with amino
acid residue numbers for each domain shown. Mass spectra obtained following limited proteolysis with trypsin of (B) atx-3(14Q) protofibrils (C)
atx-3(78Q) protofibrils and (D) atx-3(78Q) mature fibrils. Mass spectra of (left) the depolymerized fibrillar material are contrasted with those
obtained from analysis of (right) the soluble products of proteolysis. Asterisks represent species observed in the pellet fraction that were also
observed in supernatant samples ((-16)-454 and (-16)-474, respectively). Peaks identified as containing the polyQ tract are highlighted in
pink, while those representing QBP-1 are highlighted in orange.
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less disorder in atx-3(78Q) than in atx-3(14Q) for these spe-
cies and thus suggests that the expanded polyQ region is in a
compact conformation that is more stable and less prone to
unfolding than other parts of the atx-3 molecule.)
The Conformational Dynamics of the JD Are Altered in
PolyQ-Expanded Atx-3—As the global conformations ad-
opted by atx-3(14Q) and atx-3(78Q) in their monomeric states
were observed to be similar by ESI-IMS-MS, we next inves-
tigated whether the local conformational dynamics of the JD
are perturbed upon polyQ expansion. Atx-3(14Q) and atx-
3(78Q) were each subjected to limited proteolysis with trypsin
and the resulting products identified by ESI-IMS-MS in real
time. The C-terminal intrinsically disordered region of atx-3 in
both constructs was digested rapidly, and cleavage also oc-
curred at sites within the dynamic 2/3 hairpin of the JD (at
residues R45, R47, and R59, leading to fragments (-16)-45
and 48–59) (Figs. 4A and 4B). The JD core region was not
unfolded by these cleavage events and accumulated as a
stable product of limited proteolysis (60–182) (also the stable
product incorporating residues 60–190 was formed). The ob-
servation of the same major stable proteolysis products for
both atx-3(14Q) and atx-3(78Q) suggests that each protein
has similar conformational stability, consistent with previous
results (22). Importantly, however, several peptides originating
from the JD were observed when atx-3(78Q) was digested
(60–85, 86–101, 129–182, 167–182) that were not observed
for atx-3(14Q) (Figs. 4B and 4C). Accordingly, residues K85,
R101, K128, and K166 were exposed (or became exposed) for
a sufficiently long time period to allow trypsin cleavage in
atx-3(78Q) but were not exposed for a sufficient time for
cleavage to occur in atx-3(14Q) under the conditions studied.
The 2/3 hairpin of the JD is the only highly dynamic
region of the JD exhibiting extensive local motions (as judged
by NMR relaxation measurements (36, 37)). K85 interacts with
this region, and so this residue could become exposed tran-
siently to proteinase during native dynamic movement of the
JD (Fig. 4C). By contrast, residues R101, K128, and K166,
while surface-exposed (Fig. 4C), are not within dynamic re-
gions (36) and so must be involved in local interactions that
restrict their cleavage. For JD cleavage products to be ob-
served upon limited proteolysis of atx-3(78Q) that are not
observed for atx-3(14Q), two scenarios can be proposed. The
first is that the JD populates a unique native-like conformation
in the presence of an expanded polyQ tract that is distinctively
susceptible to limited proteolysis. The second is that the JD
populates the same conformational ensemble in the presence
of an expanded polyQ tract but that the rate of conformational
transition between native-like states is altered such that the
susceptibility to proteolysis of K85 is enhanced. In the latter
case, the limited proteolysis data can be explained if cleavage
occurs at K85 first, resulting in unfolding and exposure of
residues R101, K128, and K166 for subsequent cleavage.
Consistent with this proposal, peptides 86–101, 129–182, or
167–182 are not observed before the appearance of peptide
60–85.
To distinguish between these scenarios, the appearance of
the peptide 60–85 upon limited proteolysis of the JD, atx-
3(14Q) and atx-3(78Q) was monitored in real time by use of
ESI-MS. We posited that if atx-3(78Q) populates a unique
conformation that exposes additional JD residues for cleav-
age, then K85 should not be cleaved in atx-3(14Q) or the JD.
By contrast, if conformational dynamics between native-like
states are altered in atx-3(78Q), then cleavage at K85 should
occur in atx-3(14Q) and the JD but on a slower time scale. The
results showed that the peptide 60–85 became populated
upon exposure to trypsin in all three samples but appeared at
a much faster rate for atx-3(78Q) than for atx-3(14Q) or the JD
alone (Fig. 5). Conversely, the JD peptide residues 9–45
became populated at a similar rate for all three constructs.
This suggests that the region of the JD surrounding K85 is
FIG. 3. Monomeric conformations of
atx-3. Representative ESI mass spectra
of (A) atx-3(14Q) and (B) atx-3(78Q) ob-
tained at t  0 with (C, D) respective
driftscope plots. Monomeric ion species
are shown in black, and dimeric ion spe-
cies are highlighted in orange. (E) Esti-
mated CCSs obtained for monomeric
ion species (compact charge state dis-
tribution) of atx-3(14Q) (224) and atx-
3(78Q) (). Average measurements from
three datasets are shown with error bars
representing the S.E. in each case.
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more exposed, on average, in atx-3(78Q) than in atx-3(14Q) or
the JD, reflecting an altered rate of conformational transition
between native-like states for the expanded construct in com-
parison to the JD and atx-3(14Q). The extent of any confor-
mational change resulting in 5% difference in CCS may
affect changes in proteolysis but would not be detected by
IMS-MS analyses.
Amyloid fibril formation is thought to be driven by the ex-
posure of short aggregation-prone regions (38), and the re-
gion 73–96, surrounding K85 in the JD, is one of three JD
regions (73–96, 144–154, and 159–167) predicted to be ag-
gregation prone by computational analysis (39). To determine
whether enhanced exposure of residues 73–96 affects fibril
formation, the aggregation behavior of this region was as-
sessed as an isolated synthetic peptide, as well as its influ-
ence on atx-3 aggregation. We hypothesized that if exposure
of the region 73–96 is necessary for fibril formation, then the
aggregation kinetics of atx-3 should be altered in the pres-
ence of this peptide. Peptides composed of JD residues
73–96, 144–154, and 159–167 were synthesized and incu-
bated under conditions identical to those used to study the
aggregation of atx-3 (see Methods). These peptides all
FIG. 4. Limited proteolysis of atx-3 monomers. Representative ESI mass spectra of (A) atx-3(14Q) and (B) atx-3(78Q) obtained following
limited trypsinolysis. Samples were exposed to trypsin for 15 min at 37 °C. Major stable products of proteolysis were JD residues 60–182 (dark
purple) and atx-3 residues 60–190 (light purple). The C terminus of atx-3 was digested rapidly, producing a multitude of peptides (dark gray)
and cleavage also occurred at sites within the dynamic 2/3 hairpin of the JD (peptides in light blue). Additional fragments produced by
cleavage at sites within the JD were observed for atx-3(78Q) (green). A list of all peptides identified is given in supplemental Table 1. (C)
Schematic illustrating correlation between predicted aggregation-prone regions of the JD (34) (red), additional cleavage products observed for
atx-3(78Q) (green) and the major stable products of proteolysis (purple). Amino acid numbers and secondary structure elements of the JD are
shown with potential trypsin cleavage sites in orange. Key residues are identified on a ribbon diagram of the JD (PDB Number:1YZB (32)).
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formed ThT-positive fibrils immediately upon dilution from
DMSO, resulting in a fluorescence signal that remained con-
stant over 24 h. These ThT-positive aggregates, however,
have strikingly different morphologies, with the peptide 73–96
forming curvilinear structures, similar to protofibrils formed by
the full-length JD (supplemental Fig. 2). In the presence of the
peptide 73–96, fibril formation of both atx-3(14Q) and atx-
3(78Q) was accelerated (i.e. lag times decreased, (Figs. 6A
and 6B)) while the resulting fibril morphology appeared un-
changed (Figs. 6C-6F). The peptide 73–96 exhibited a greater
effect on the aggregation rate of atx-3(78Q) than for atx-
3(14Q), as may be expected if this aggregation-prone region
is more freely available in the former construct. No effect on
atx-3 fibrillation was observed in the presence of the other JD
peptides.
Together, the results presented suggest that atx-3(78Q)
aggregates more rapidly than atx-3(14Q) because it exhibits
altered conformational dynamics that enhance the exposure
of the aggregation-prone segment (residues 73–96) of the JD
and increase the probability of forming intermolecular inter-
actions that promote amyloid assembly.
Oligomeric Species Undergo a Conformation Change dur-
ing the Lag Phase of Assembly—The population and confor-
mational characteristics of oligomers present during the lag
phase of amyloid assembly for the JD, atx-3(14Q) and atx-
3(78Q) were next monitored using ESI-IMS-MS. This analysis
revealed that a shift in the CSDs observed for monomeric and
dimeric species of the JD occurred over time (Figs. 7A and
7B); more extended monomeric species (at higher charge
states, 10, 11 and 12) were depleted relative to mono-
meric species at lower charge states (7, 8, 9) between
0 h and the midpoint of the lag phase and compact dimeric
species (at lower charge states) increased in population (rel-
ative to dimeric species at higher charge states). At 0 h
incubation, the m/z 2906 ion species of the JD consisted of a
mixture of dimeric (16) and monomeric (8) species, but by
50% through the lag phase, this dimeric ion species was
barely detectable (Figs. 7A and 7B, inset). This was accom-
panied by the appearance of pentamer and hexamer and an
increased population of dimer to tetramer (Figs. 7C–7F).
The charge state distributions of trimeric and tetrameric
species of the JD were also observed to change between 0 h
and the midpoint of the lag phase. Lower-charged trimeric
species (e.g. m/z 4648 trimer 15) and tetrameric species
(e.g. tetramer 19 and 18) became visible over time (Figs.
7E–7I) concomitant with higher-charged species being de-
pleted (e.g. m/z 3874 tetramer 24) (Figs. 7H and 7J). The
largest population of oligomers (monomer to hexamer) was
detected between 7 and 9 h of incubation (50% lag phase). By
the end of the lag phase, higher-order oligomers were no
longer detectable and only free monomer and dimer could be
seen (supplemental Fig. 3).
In agreement with observations made for the JD, a shift in
the monomeric, dimeric, and trimeric CSDs of atx-3(14Q) and
atx-3(78Q) was observed to occur over the incubation time
with more extended monomeric conformations becoming de-
pleted as more compact oligomeric species formed (supple-
mental Fig. 4). Oligomers were also observed to form more
rapidly for atx-3(78Q) than atx-3(14Q), consistent with the
decreased lag time of atx-3(78Q) aggregation. Again, the larg-
est population of oligomeric species (monomer to trimer) was
observed at the midpoint of the lag phase of assembly for
each construct.
FIG. 5. Limited proteolysis of atx-3 constructs over time. Representative ESI mass spectra of (A) JD, (B) atx-3(14Q), and (C) atx-3(78Q)
obtained following exposure to trypsin (10:1 protein: enzyme molar ratio) at 37 °C for (top) 1 min, (middle) 4 min and (bottom) 8 min,
respectively. Spectra are normalized to the relative intensity of a control peptide (JD 48–59) added at a 5:1 protein: peptide molar ratio. (*)
Partially digested fragments of atx-3 (●) Sodiated peptide ions.
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These observations suggest that oligomers of the JD, atx-
3(14Q), and atx-3(78Q) are formed via equivalent processes,
with more compact conformations of dimeric and higher-
order oligomeric species becoming relatively more highly
populated during the lag phase of aggregation. As only mono-
mers, dimers, and trimers are observed for atx-3(14Q) and
atx-3(78Q), there are insufficient data to fit a model directly for
these proteins. The same changes in the charge state distri-
butions of the three species through the lag phase of aggre-
gation are observed, however, and the protofibril core is the
same for each species, suggesting a similar process is being
undertaken. If so, then this could reflect conformational
changes in the JD, previously observed by others to occur
during oligomerization and suggested to be the first step on
the aggregation pathway (19). To explore this in more detail,
CCSs were estimated from the IMS-MS data for the most
compact form of each JD oligomer observed after 50% of the
lag phase of aggregation. The oligomers were observed to
increase in CCS with increasing oligomer number in a linear
fashion (Fig. 7K). The estimated CCSs were compared with
those expected based on different models of assembly: iso-
tropic, linear, ring, and linear subsequent to dimerization (see
Methods). The data fit best to a model in which a linear
increase in CCS with oligomer number is observed only after
dimerization. This model suggests that there is a conforma-
tional change upon dimer formation, or within the dimer, that
results in a template for further monomer addition.
DISCUSSION
The results presented provide an increased understanding
of atx-3 fibril formation in vitro and provide a rationale for the
different rates of fibrillation observed for nonexpanded and
polyQ-expanded atx-3. From these data, a detailed model for
the mechanism of fibril formation can be proposed (Fig. 8).
Aggregation of atx-3 occurs initially through self-associa-
tion of the JD from a native or near-native conformation (40,
41). Atx-3 with an expanded polyQ tract aggregates at a faster
rate than nonexpanded atx-3, yet the presence of an ex-
panded polyQ tract does not appear to affect the global
stability or unfolding/folding rates of the JD (22). Results of the
limited proteolysis experiments presented here suggest that
the rate of conformational transitions between native-like
states in the JD of atx-3(78Q) are altered such that residue
K85 is more exposed for proteolysis (Fig. 8(I)). This results
likely in exposure of the aggregation-prone region 73–96 for
longer periods of time, increasing the probability of aberrant
intermolecular interactions and thus enhancing the rate of
aggregation (Fig. 8(II)). The peptide 73–96 forms protofibrils of
similar morphology to those formed by atx-3, and this peptide
also enhances the rate of atx-3 aggregation, suggesting that
FIG. 6. Fibril formation of atx-3 in the presence of JD peptides. The effect of the presence of the JD peptides 48–59, 73–96, 144–154
and 159–167 on the lag time of fibril formation for (A) atx-3(14Q) and (B) atx-3(78Q) (n  6, 1:1 protein: peptide molar ratio, 20 M protein in
250 mM ammonium bicarbonate, 1 mM DTT, pH 8.1, 37 °C without shaking) and corresponding TEM images taken after 48 h incubation for (C)
atx-3(14Q), (D) atx-3(14Q)  73–96 1:1, (E) atx-3(78Q) and (F) atx-3(78Q)  73–96 1:1. Scale bars  100 nm.
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this region is involved in initial aggregate formation. Impor-
tantly, other peptides, although assembling into amyloid-like
fibrils but with a different morphology, did not result in a rate
enhancement. Previous studies have also shown that muta-
tions within the 73–96 region of the JD (I77K/Q78K and W87K
designed to reduce surface hydrophobicity (39) and S81A
FIG. 7. JD oligomerization. ESI-IMS-MS data obtained upon analysis of the JD (top) before aggregation (t  0 h) and (bottom) at 50% through
the lag phase of aggregation (8 h), as monitored by ThT fluorescence. (A, B) Representative ESI mass spectra with insets showing extracted ATDs for
the m/z 2906 ion species. Monomer (black), D  dimer (orange). (C, D) Driftscope plots of (A) and (B), respectively. (E, F) Driftscope plots showing the
oligomeric species in (C) and (D), respectively with MS spectra inset, T  trimer (blue) and Q  tetramer (purple). Dashed boxes highlight trimeric and
tetrameric species (E, inset) absent at 0 h incubation and (F, inset) present at 50% through the lag phase of aggregation. Extracted ATDs for (G, I) the
m/z 4648 ion species and (H, J) the m/z 3874 ion species at 0 h and 50% of the lag phase, respectively. (K) Oligomers increase in CCS with oligomer
number in a linear fashion. Experimentally derived CCSs (black diamonds). Various models of oligomer assembly are shown: ring (blue), linear (purple),
isotropic (black), and linear after dimerization (orange). The data best fit a model of linear assembly after dimerization (orange dashed line).
FIG. 8. Model of the mechanism of fibril formation for non-expanded and polyQ-expanded atx-3. Monomeric atx-3 exposes its aggregation-
prone region (residues 73–96), situated within the JD, transiently during native protein dynamics. In polyQ-expanded atx-3 these dynamic motions are
perturbed, exposing this aggregation-prone region for longer time periods (I) and resulting in faster oligomerization (II). A conformational change within
the JD occurs upon dimer formation, or within the dimer, that provides a template for further monomer addition (III). Oligomers increase in CCS with
subunit number in a linear fashion after dimerization (IV). Protofibrils are formed in which the core involves JD residues between 62 and 182 (V). In
polyQ-expanded atx-3, these protofibrils are able to mature into SDS-resistant fibrils by the formation of a network of intermolecular interactions between
polyQ regions (VI). The two fibril cores are independent and structural rearrangement of the protofibril core is not required for mature fibril formation.
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designed to increase stability (42)) result in reduced aggrega-
tion rates. How the presence of an expanded polyQ tract
alters the conformational dynamics of the JD is unclear. The
experiments presented here, and previous NMR experiments
(43), provide no evidence for a stable interaction between the
JD and the polyQ region. The polyQ region may therefore
create a local denaturing environment, lowering the energy
barrier for formation of an aggregation-prone native-like state
and/or holding the JD in an aggregation-prone conformation
for longer periods of time. This is not unprecedented as
polyglutamine has been shown to have a urea-like affinity for
unfolded polypeptides (44) and to reduce the global stability
of neighboring protein domains in fusion constructs (45).
ESI-IMS-MS analysis of oligomers formed during the lag
phase of atx-3 aggregation showed that a conformational
change in the oligomer population occurred over time, such
that more compact conformations became relatively more
populated. Modeling of the CCSs of the JD oligomers ob-
served suggests that a conformational change occurs at the
dimer level (Fig. 8(III)). This is consistent with previous studies
that showed that atx-3 aggregation can be seeded by the
addition of preformed dimers and that these dimers display an
increased -sheet content and are recognized by the anti-
oligomer antibody A11 (19). Here, using ESI-IMS-MS, we
show that oligomerization of the JD was observed to proceed
by a linear growth model after initial dimerization, consistent
with the formation of elongated oligomeric assemblies (Fig.
8(IV)). Finally, analysis of the cores of protofibrils and mature
SDS-resistant fibrils of atx-3 by use of limited proteolysis and
MS analyses confirmed that the polyQ region is not structur-
ally involved in protofibril formation (Fig. 8(V)). Formation of
mature fibrils involves the independent polymerization of ex-
panded polyQ regions, and our results show that this pro-
ceeds without requiring substantial alteration of the protofibril
core (Fig. 8(VI)).
There is debate within the literature as to the mechanism of
toxicity for all amyloid diseases, including Machado-Joseph
disease. C-terminal fragments containing the polyQ tract, as
well as the full-length protein, are found in neuronal inclusions
(46), yet inclusion load does not correlate well with disease
burden. FTIR spectroscopy experiments have provided evi-
dence that the aggregation of polyQ-expanded atx-3 in vivo
proceeds through the two-step mechanism observed in vitro
(47), and soluble aggregates formed in the first stage of this
process have been shown to be cytotoxic (47). The sites of
ubiquitin binding (I77/Q78 and W87) (48) are contained within
the aggregation-prone region of the JD (residues 73–96), sug-
gesting that native functional interactions will ordinarily pro-
tect against aggregation (39). In the presence of an expanded
polyQ tract, the enhanced propensity to aggregate may over-
come these protective functional interactions. Indeed, nonex-
panded atx-3 has been shown to form intranuclear inclusions
under cell stress (49, 50). This highlights the importance of
defining the nature of atx-3 conformational changes and
oligomerization at the nanoscale level to understanding of the
disease process. Here, we show how ESI-IMS-MS analyses
can contribute toward a detailed understanding of aggrega-
tion processes, from monomer through to fibril, revealing
unprecedented details of the mechanism of aggregation in
atx-3 and rationalizing why an expanded polyQ tract en-
hances the rate of aggregation.
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